
|Articles|July 27, 2006
Poniard Appoints Chief Medical Officer
Author(s)BioPharm International Editors
Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer.
Advertisement
Poniard Pharmaceuticals, Inc. (Seattle, WA,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Generative AI and Adaptive Trials Shape Future Biotech Development
3
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5




